Heather A. Wakelee, MD
, thoracic oncologist and professor of medicine at Stanford University Medical Center, discusses the decisions that go into planning treatments for newly diagnosed, advanced stage lung cancer patients. For patients with suspected driver mutations, Dr. Wakelee recommends chemotherapy and, in some cases, bevacimuzab. For patients not likely to have driver mutations, a combination of chemotherapy and immunotherapy is the recommended treatment.
Learn more by clicking here